Recently, TrialSite News reported on an Australian research team (Monash University & Peter Doherty Institute) uncovering the potential that ivermectin could potentially be used as a treatment against COVID-19. Recently, the U.S. Food and Drug Administration (FDA) had to warn people not to self-mediate with ivermectin-based products intended for animals, thinking they can be used for ivermectin intended for humans.
The Work in Australia
TrialSite News reported that a collaborative effort involving Monash University’s Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity at Royal Melbourne Hospital published the results revealing that ivermectin, an approved anti-parasitic drug available worldwide, may actually treat against SARS-CoV-2 when applied to an infected cell culture. Of course, this test was done in a lab a not on real people so there is much work to do to evaluate these findings.
Remind People not to take Drugs not Approved!
In the meantime, the FDA’s Center for Veterinary Medicine became aware lately of increased public visibility of the antiparasitic drug after the research announcement. Hence, the FDA must of...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).